Mulmit

ATOSSA THERAPEUTICS, INC.ATOSSA THERAPEUTICS, INC.

ATOS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2015-12-311,758-12,758,618-15,760,323
2014-12-3140,138-12,171,028-14,657,926
2013-12-31632,558-10,784,643-10,784,708
2012-12-31481,842-5,069,030-5,079,851
2011-12-311,500-3,429,190-3,442,268

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-05-12Steinhart Richard I10,000
2026-05-12Chen Shu-Chih10,000
2026-05-12Remmel H. Lawrence10,000
2026-05-12Finn Jonathan10,000
2026-05-12Galli Stephen J10,000
2026-05-12Cigler Tessa10,000
2026-03-27QUAY STEVEN CPresident & CEO65,000
2026-03-26Daniel Mark JamesChief Financial Officer63,000
2026-01-20QUAY STEVEN CPresident & CEO325,203
2026-01-20QUAY STEVEN CPresident & CEO950,000
2025-10-14Daniel Mark JamesChief Financial Officer578,000
2025-05-21QUAY STEVEN CPresident & CEO11,239

8-K events

FiledItems
2026-08-07Results of operations · Financial statements and exhibits
2026-06-11Entry into a material agreement · Financial statements and exhibits
2026-05-08Financial statements and exhibits
2026-05-08Submission of matters to a vote
2026-04-16Other events
2026-03-25Financial statements and exhibits
2026-02-20Entry into a material agreement · Termination of a material agreement · Financial statements and exhibits
2026-02-17Delisting or listing-standard notice
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.